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Previewslikelihood that cytoplasmic Mad2
would interact with kinetochore-localized
Mad1, and thus a greater proportion of
the Mad2 population would be converted
to an active state, resulting in more
MCC. In addition, a smaller cytoplasmic
volume would decrease the distance
over which the MCC would need to
diffuse. If the concentration of the
APC/C has not increased, inhibition by
the MCC would be favored (Figure 1).
Mathematical modeling would prove
a valuable test of this hypothesis and indi-
cate whether additional parameters, such
as MCC disassembly factors, need to be
included. A comprehensive model would
consider how changes in cell size affect
the distribution of kinetochores in the
cytoplasm, as it has recently been shown
that the size of condensed chromosomes
also scale with cell size (Ladouceur et al.,
2015; Levy and Heald, 2012). Experimen-
tally, it would be important to determine
whether small cells have a greater con-
centration of assembled MCC, even if
the concentration of its individual constit-246 Developmental Cell 36, February 8, 2016uents does not change. There is also the
question as to whether the MCC needs
to inhibit the entire cytoplasmic pool of
APC/C or whether it is sufficient to block
APC/C activity in the vicinity of the mitotic
spindle, where at least some of its sub-
strates are enriched (e.g., Hagting et al.,
1998).
Recent studies have established that
the size of many subcellular structures,
including the mitotic spindle, the nucleus,
and condensed chromosomes, scales to
cell size (Levy and Heald, 2012). These
findings raise the interesting question of
how changes in cell size may also impact
signaling activities. The work of Galli and
Morgan (2016) demonstrates that the ac-
tivity of a key cell-cycle regulator, the
SAC, is indeed sensitive to cell size and
is influenced by the increase in kineto-
chore-to-cytoplasmic ratio that occurs
during normal embryonic development.
Further uncovering the mechanisms that
govern these types of changes, and,
importantly, how differently sized cells
buffer against them to ensure a stabilityª2016 Elsevier Inc.of output, will be of particular interest in
the future.
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Toll and Hippo are two seemingly disparate pathways that regulate innate immunity and tissue
growth, respectively. Reporting recently in Cell, Liu et al. (2016) tie them together by demonstrating that
microbial infection activates Toll, which then signals to both pathways to modulate the antimicrobial
response.It was quite a surprise some 20 years ago
when the maternal Toll-NFkB pathway—
originally identified to control dorsal-
ventral patterning of early Drosophila
embryos—was found to also be em-
ployed to control innate immune response
in larvae and adults (Ip et al., 1993; Le-
maitre et al., 1996). That discovery invigo-
rated the research on innate immunity, the
identification of Toll-like receptors, and
the link between innate and adaptive
immunity. A recent paper by Liu et al.
(2016), published in Cell, brings usanother pleasant surprise in the field: the
kinase Pelle, acting downstream of Toll,
can phosphorylate and inhibit the Cka-
phosphatase complex that represses
Hippo. This cross-regulation between
Toll and Hippo signaling then influences
innate immunity gene expression.
Activation of the Toll pathway is initi-
ated by pattern recognition of peptidogly-
cans fromGram-positive bacteria (Gobert
et al., 2003). A cascade of upstream
protease cleavage events then leads to
the processing of Spa¨tzle, which bindsto the trans-membrane protein Toll (Fig-
ure 1). This causes the recruitment of the
adaptor complex, activation of the kinase
Pelle, phosphorylation and degradation
of the inhibitor Cactus, and nuclear trans-
location of the NF-kB transcription factors
Dorsal and DIF to regulate immunity gene
expression.
The Tao-Hippo-Warts kinase pathway
phosphorylates and inhibits the transcrip-
tional co-activator Yorkie, which controls
tissue growth by regulating the cell cycle
and antiapoptotic genes (Figure 1). In their
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Figure 1. Biological Processes Regulated by the Toll and Hippo Pathways
The most notable function of the Hippo pathway is growth regulation in developing imaginal discs, while
that of the Toll pathway is embryonic dorsal-ventral patterning and adult immune response. Liu et al. (2016)
find that Toll-Pelle also regulate Hippo activity in the fly fat body in immune response, thus providing a
model for further investigation of Toll-Hippo interaction in other tissues, such as the imaginal disc and
intestine. Abbreviations: Hpo (Hippo), Yki (Yorkie), Sd (Scalloped), CycE (Cyclin E), Cka (Connector of
kinase to AP-1), Spz (Spa¨tzle), Pll (Pelle), Cact (Cactus), Dl (Dorsal), DIF (Dorsal-related immunity factor),
AMP (antimicrobial peptide), dpp (decapentaplegic), sna (snail), Upd3 (Unpaired 3), BM (basement
membrane), VM (visceral muscle), ISC (intestinal stem cell), EB (enteroblast), EC (enterocyte), EE (enter-
oendocrine cell).
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Previewsstudy, Liu et al. (2016) show that RNAi-
mediated Hippo loss of function in fat
bodies, the major tissue for producing
antimicrobial peptides, exhibits theclassic
immune deficiency phenotype. Similar ex-
periments with Warts knockdown and
Yorkie expression demonstrate that the
canonical Hippo pathway functions in fat
bodies aspart of innate immunity. Interest-
ingly, infection with Gram-positive bacte-
ria and fungi, but not Gram-negative
bacteria, cause increased lethality in the
absence of Hippo function. This immune
phenotype is very similar to that observed
with the loss of Toll pathway function.
The authors then used a series of ge-
netic and biochemical experiments to
find the link between Toll and Hippo. The
Hippo kinase activity depends on its
association with other components teth-
ering to the cytoplasmic membrane.The STRIPAK (Striatin-interacting phos-
phatase and kinase) complex at themem-
brane functions as an inhibitor by
providing the phosphatase activity toward
Hippo. The authors demonstrate that
Pelle phosphorylates Cka of the STRIPAK
complex, thereby causing degradation
of this inhibitory protein to increase Hippo
activity. They also found that if the
Hippo function is lost, Yorkie can increase
the transcription of cactus. Thus, under
normal physiological conditions, in order
for the fly to have an efficient immune
response upon detection of infection,
Pelle activated by Toll has the dual func-
tion of directing Cactus protein degrada-
tion, as previously appreciated, and of in-
hibiting cactus gene transcription through
the Hippo pathway (Figure 1).
While the authors uncover an immune
function for Hippo, it is intriguing toDevelopmental Cell 36consider why Toll pathway mutants do
not have obvious growth defects. The
Toll10b used by Liu et al. (2016) is a strong
gain-of-function allele and has been used
widely to show increased immunity gene
expression and maternally derived dor-
sal-ventral patterning defect. No growth
defects, as observed after loss of Yorkie
function, have been noted in the Toll10b
mutant flies. Perhaps more assays based
on this Toll-Hippo interaction model may
unveil some hidden functions of Toll in tis-
sue growth. Another interesting question
is the dual function of Pelle as a kinase to-
ward Cka and Cactus (Figure 1). In addi-
tion to Cka, another substrate that can
bind to and be phosphorylated by Pelle
is the HMG domain protein Dichaete dur-
ing oogenesis, elegantly demonstrated by
the late John Nambu and colleagues
(Mutsuddi et al., 2010). However, Pelle
cannot bind directly to Cactus, even
though it can phosphorylate Cactus
in vitro (Daigneault et al., 2013), leaving
the possibility that there is still an un-
identified component between Pelle and
Cactus.
Overall, the findings of Liu et al. (2016)
provide a model to investigate many
important biological questions, such as
whether Pelle and Cka can also regu-
late other Hippo-related Ste20 kinases
(including Misshapen and Happyhour),
which have recently been shown to acti-
vate Warts in different cellular contexts (Li
et al., 2014; Zheng et al., 2015). Moreover,
a recent report suggests that cell com-
petition in imaginal discs involves some
Toll pathway components to regulate
apoptosis (Meyer et al., 2014). Thus, it is
of obvious interest to determine whether
the Toll and Hippo pathways are linked in
cell competition. Lastly, some of the Toll-
related proteins in Drosophila, Toll-2 to
Toll-9, have been shown to act in various
processes such as neuromuscular junc-
tion development (Sutcliffe et al., 2013).
These provide further avenues to examine
the relevance of the principle regulatory
relationship uncovered by Liu et al. (2016)
between Pell and Cka/Hippo.
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